{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:08:09Z","timestamp":1788826089224,"version":"build-2803163510"},"reference-count":152,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The surface of cancer cells is covered in abnormal carbohydrate antigens that facilitate tumor growth, immune evasion and metastasis. Overexpressed and often specific to cancer cells, these tumor-associated carbohydrate antigens (TACAs) offer a valuable handle for targeted immunotherapy and were soon targeted by TACA\u2013protein conjugate vaccines. Despite good initial results, sTn-KLH conjugate Theratope\u00ae failed in clinical trials fifteen years ago for failure to improve life expectancy. This has been attributed to poor immunogenicity, inhomogeneous expression of TACAs within tumors, and vaccine carrier interference. This review covers the two decades of subsequent effort to overcome these limitations and the now large toolbox available to vaccine researchers to improve the outcome of anticancer vaccines: analogues and conformation-locked mimics of TACAs, monomolecular multivalent vaccines, more biologically relevant presentation of TACAs through clusters and glycopeptides, and a new generation of vaccine carriers to reduce carrier interference, immune reaction, or provide simple modular vaccine delivery platforms.<\/jats:p>","DOI":"10.3390\/vaccines14040287","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:02:49Z","timestamp":1774339369000},"page":"287","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Conjugate Vaccines Targeting Tumor-Associated Carbohydrate Antigens"],"prefix":"10.3390","volume":"14","author":[{"given":"Nadine","family":"Rosenglick","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, 2801 W. Bancroft St., Toledo, OH 43606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9414-8099","authenticated-orcid":false,"given":"G\u00e9raud","family":"Valentin","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, 2801 W. Bancroft St., Toledo, OH 43606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Marineni","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, 2801 W. Bancroft St., Toledo, OH 43606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euclydes P.","family":"Neto","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, 2801 W. Bancroft St., Toledo, OH 43606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Andreana","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, 2801 W. Bancroft St., Toledo, OH 43606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global Cancer Incidence and Mortality Rates and Trends\u2014An Update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The Ever-Increasing Importance of Cancer as a Leading Cause of Premature Death Worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/CEJ.0000000000000594","article-title":"Progress in Cancer Mortality, Incidence, and Survival: A Global Overview","volume":"29","author":"Santucci","year":"2020","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_4","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1039\/D3MD00746D","article-title":"1,5-Disubstituted Tetrazoles as PD-1\/PD-L1 Antagonists","volume":"15","author":"Draijer","year":"2024","journal-title":"RSC Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd3500","article-title":"Cancer Immunotherapy\u2014Revisited","volume":"10","author":"Lesterhuis","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Falzone, L., Salomone, S., and Libra, M. (2018). Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01300"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of Precision Cancer Medicine: Evolution of the Treatment Paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20503121211034366","DOI":"10.1177\/20503121211034366","article-title":"New Approaches and Procedures for Cancer Treatment: Current Perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"Sage Open Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic Virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrc1950","article-title":"Preventing or Reducing Late Side Effects of Radiation Therapy: Radiobiology Meets Molecular Pathology","volume":"6","author":"Bentzen","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","first-page":"86","article-title":"A Review of Cancer Immunotherapy Toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Berois, N., Pittini, A., and Osinaga, E. (2022). Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. Cancers, 14.","DOI":"10.3390\/cancers14030645"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/biom2040435","article-title":"Sialyl-Tn in Cancer: (How) Did We Miss the Target?","volume":"2","author":"Julien","year":"2012","journal-title":"Biomolecules"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdcr.2024.08.004","article-title":"Polysensitive Radiation Recall Dermatitis Following Prevnar 20 Vaccination","volume":"52","author":"Rodriguez","year":"2024","journal-title":"JAAD Case Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer Immunoediting: From Immunosurveillance to Tumor Escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_18","unstructured":"Varki, A., Cummings, R.D., Esko, J.D., Stanley, P., Hart, G.W., Aebi, M., Mohnen, D., Kinoshita, T., Packer, N.H., and Prestegard, J.H. (2022). Glycosyltransferases and Glycan-Processing Enzymes. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/anie.201002313","article-title":"The Tn Antigen\u2014Structural Simplicity and Biological Complexity","volume":"50","author":"Ju","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101389","DOI":"10.1016\/j.smim.2020.101389","article-title":"Tumor-Associated O-Glycans of MUC1: Carriers of the Glyco-Code and Targets for Cancer Vaccine Design","volume":"47","author":"Beckwith","year":"2020","journal-title":"Semin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1021\/acs.jmedchem.7b01242","article-title":"Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs","volume":"60","author":"Artigas","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.4049\/jimmunol.172.12.7341","article-title":"Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell","volume":"172","author":"Monti","year":"2004","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research","volume":"15","author":"Cheever","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_24","first-page":"431","article-title":"Expressions of Lewis Antigens in Human Non-Small Cell Pulmonary Cancer and Primary Liver Cancer with Different Pathological Conditions","volume":"22","author":"Wang","year":"2003","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3892\/ijmm.2017.3009","article-title":"Lewis(y) Antigen Promotes the Progression of Epithelial Ovarian Cancer by Stimulating MUC1 Expression","volume":"40","author":"Hou","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4240\/wjgs.v12.i12.468","article-title":"Carbohydrate Antigen 19-9\u2014Tumor Marker: Past, Present, and Future","volume":"12","author":"Lee","year":"2020","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/fon-2021-1110","article-title":"The Role of Globo H and SSEA-4 in the Development and Progression of Cancer, and Their Potential as Therapeutic Targets","volume":"18","author":"Sigal","year":"2022","journal-title":"Future Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/glycob\/cwv032","article-title":"Expression of Stage-Specific Embryonic Antigen-4 (SSEA-4) Defines Spontaneous Loss of Epithelial Phenotype in Human Solid Tumor Cells","volume":"25","author":"Sivasubramaniyan","year":"2015","journal-title":"Glycobiology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/j.1460-2075.1983.tb01746.x","article-title":"Stage-specific Embryonic Antigens (SSEA-3 and -4) Are Epitopes of a Unique Globo-series Ganglioside Isolated from Human Teratocarcinoma Cells","volume":"2","author":"Kannagi","year":"1983","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1073\/pnas.1400283111","article-title":"Stage-Specific Embryonic Antigen-4 as a Potential Therapeutic Target in Glioblastoma Multiforme and Other Cancers","volume":"111","author":"Lou","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1158\/0008-5472.CAN-14-1651","article-title":"Globo-H Ceramide Shed from Cancer Cells Triggers Translin-Associated Factor X-Dependent Angiogenesis","volume":"74","author":"Cheng","year":"2014","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Cao, S., Hu, X., Ren, S., Wang, Y., Shao, Y., Wu, K., Yang, Z., Yang, W., He, G., and Li, X. (2023). The Biological Role and Immunotherapy of Gangliosides and GD3 Synthase in Cancers. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1076862"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ijc.2910530407","article-title":"Ganglioside Expression on Human Malignant Melanoma Assessed by Quantitative Immune Thin-Layer Chromatography","volume":"53","author":"Hamilton","year":"1993","journal-title":"Int. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0005-2760(98)00096-4","article-title":"Natural Forms of Shed Tumor Gangliosides","volume":"1394","author":"Kong","year":"1998","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Lipids Lipid Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40265-021-01467-4","article-title":"Naxitamab: First Approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11523-022-00930-w","article-title":"Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma","volume":"18","author":"Balaguer","year":"2022","journal-title":"Target. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present Yourself! By MHC Class I and MHC Class II Molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2051013614525375","article-title":"MHC Class I Antigen Presentation and Implications for Developing a New Generation of Therapeutic Vaccines","volume":"2","author":"Comber","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"126931","DOI":"10.1016\/j.vaccine.2025.126931","article-title":"A Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Toddlers Previously Vaccinated in Infancy with 13-Valent Pneumococcal Conjugate Vaccine","volume":"53","author":"Martinez","year":"2025","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2024","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2022060428","DOI":"10.1542\/peds.2022-060428","article-title":"Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 Study","volume":"152","author":"Banniettis","year":"2023","journal-title":"Pediatrics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5876(95)01319-9","article-title":"Effect of Haemophilus Influenzae Type b Conjugate Vaccine in Combination with Peroral Immunization with Escherichia Coli on Experimental Otitis Media","volume":"36","author":"Melhus","year":"1996","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.15585\/mmwr.mm6516a3","article-title":"Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus Influenzae Type b (Hib) Vaccination Series","volume":"65","author":"Briere","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1542\/peds.85.4.676","article-title":"Haemophilus Influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB): Clinical Evaluation","volume":"85","author":"Ahonkhai","year":"1990","journal-title":"Pediatrics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00207-09","article-title":"Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra","volume":"16","author":"Reisinger","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.147","article-title":"Menveo\u00ae: A Novel Quadrivalent Meningococcal CRM197 Conjugate Vaccine against Serogroups A, C, W-135 and Y","volume":"10","author":"Cooper","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sui, X., Shao, Z., Ji, Y., Wang, H., Xu, Q., Wei, B., Duan, Z., Wang, C., Yang, Y., and Zhao, J. (2025). An Evaluation of the Safety, Immunogenicity, and Protective Efficacy of a Combined Diphtheria\u2013Tetanus\u2013Acellular Pertussis, Haemophilus Influenzae Type b, and ACYW135 Meningococcal Conjugate Vaccine in Murine and Rat Models. Vaccines, 13.","DOI":"10.3390\/vaccines13070724"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2507912","DOI":"10.1080\/21645515.2025.2507912","article-title":"Comparative Immune Response of Typbar TCV\u00ae (Typhoid Conjugate Vaccine) in Extremes of Age: An Indian Experience","volume":"21","author":"Vadrevu","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100611","DOI":"10.1016\/j.ijregi.2025.100611","article-title":"Safety and Immunogenicity of Biological E\u2019s Typhoid Conjugate Vaccine TYPHIBEV\u00ae Concomitantly Administered with Measles Rubella Vaccine: A Phase IV Prospective, Multicenter Study","volume":"15","author":"Thuluva","year":"2025","journal-title":"IJID Reg."},{"key":"ref_50","first-page":"100750","article-title":"Real-World Effectiveness of the Heterologous SOBERANA-02 and SOBERANA-Plus Vaccine Scheme in 2-11 Years-Old Children during the SARS-CoV-2 Omicron Wave in Cuba: A Longitudinal Case-Population Study","volume":"34","year":"2024","journal-title":"Lancet Reg. Health Am."},{"key":"ref_51","first-page":"197","article-title":"GD3 Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines","volume":"54","author":"Helling","year":"1994","journal-title":"Cancer Res."},{"key":"ref_52","first-page":"874","article-title":"Induction of Antibodies against GM2 Ganglioside by Immunizing Melanoma Patients Using GM2-Keyhole Limpet Hemocyanin + QS21 Vaccine: A Dose-Response Study","volume":"6","author":"Chapman","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s002620050287","article-title":"Pre-Immunotherapy Serum CA27.29 (MUC-1) Mucin Level and CD69+ Lymphocytes Correlate with Effects of Theratope Sialyl-Tn-KLH Cancer Vaccine in Active Specific Immunotherapy","volume":"42","author":"Reddish","year":"1996","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1039\/c1md00033k","article-title":"Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine Candidates","volume":"2","author":"Yu","year":"2011","journal-title":"MedChemComm"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11140","DOI":"10.1021\/ja403609x","article-title":"Synthesis and Vaccine Evaluation of the Tumor-Associated Carbohydrate Antigen RM2 from Prostate Cancer","volume":"135","author":"Chuang","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2012.47.9303","article-title":"Adjuvant Ganglioside GM2-KLH\/QS-21 Vaccination versus Observation after Resection of Primary Tumor > 1.5 Mm in Patients with Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial","volume":"31","author":"Eggermont","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1007\/BF01470995","article-title":"Keyhole Limpet Hemocyanin Conjugate Vaccines against Cancer: The Memorial Sloan Kettering Experience","volume":"127","author":"Musselli","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.2217\/fon-2022-0812","article-title":"GLORIA: Phase III, Open-Label Study of Adagloxad Simolenin\/OBI-821 in Patients with High-Risk Triple-Negative Breast Cancer","volume":"18","author":"Rugo","year":"2022","journal-title":"Future Oncol."},{"key":"ref_59","first-page":"315","article-title":"Tolerance and Immunity to MUC1 in a Human MUC1 Transgenic Murine Model","volume":"58","author":"Rowse","year":"1998","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"110888","DOI":"10.1016\/j.biopha.2020.110888","article-title":"A Review on Development of MUC1-Based Cancer Vaccine","volume":"132","author":"Gao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.7150\/ijms.35452","article-title":"Evaluation of a Novel Monoclonal Antibody against Tumor-Associated MUC1 for Diagnosis and Prognosis of Breast Cancer","volume":"16","author":"Stergiou","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1002\/tcr.202100182","article-title":"The Development of Vaccines from Synthetic Tumor-Associated Mucin Glycopeptides and Their Glycosylation-Dependent Immune Response","volume":"21","author":"Stergiou","year":"2021","journal-title":"Chem. Rec."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/glycob\/cwj044","article-title":"Chemoenzymatically Synthesized Multimeric Tn\/STn MUC1 Glycopeptides Elicit Cancer-Specific Anti-MUC1 Antibody Responses and Override Tolerance","volume":"16","author":"Reis","year":"2006","journal-title":"Glycobiology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nchembio.2007.25","article-title":"Robust Immune Responses Elicited by a Fully Synthetic Three-Component Vaccine","volume":"3","author":"Ingale","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"47330","DOI":"10.18632\/oncotarget.17646","article-title":"A Cancer Vaccine Based on Fluorine-Modified Sialyl-Tn Induces Robust Immune Responses in a Murine Model","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Liu, Y., Li, B., Zheng, X., Xiong, D., and Ye, X. (2023). Cancer Vaccines Based on Fluorine-Modified KH-1 Elicit Robust Immune Response. Molecules, 28.","DOI":"10.3390\/molecules28041934"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3762\/bjoc.8.126","article-title":"Synthesis of 4\u201d Manipulated Lewis X Trisaccharide Analogues","volume":"8","author":"Moore","year":"2012","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/cb100287q","article-title":"Enhancement of the Immunogenicity of Synthetic Carbohydrate Vaccines by Chemical Modifications of STn Antigen","volume":"6","author":"Yang","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Urban, D., Skrydstrup, T., Beau, J.-M., and Skrydstrup, T. (1998). First Synthesis of a C-Glycoside Anologue of a Tumor-Associated Carbohydrate Antigen Employing Samarium Diiodide Promoted C-Glycosylation. Chem. Commun., 955\u2013956.","DOI":"10.1039\/a801196f"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/bc700411w","article-title":"Calix[4]Arene Decorated with Four Tn Antigen Glycomimetic Units and P3CS Immunoadjuvant: Synthesis, Characterization, and Anticancer Immunological Evaluation","volume":"19","author":"Geraci","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/jacs.8b13503","article-title":"Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O\/S or O\/Se Substitutions at the Glycosidic Linkage","volume":"141","author":"Guerreiro","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9830","DOI":"10.1002\/anie.201502813","article-title":"Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an Anti-MUC1 Antibody","volume":"54","author":"Madariaga","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"10968","DOI":"10.1021\/jo4019396","article-title":"A Double Diastereoselective Michael-Type Addition as an Entry to Conformationally Restricted Tn Antigen Mimics","volume":"78","author":"Aydillo","year":"2013","journal-title":"J. Org. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"101250","DOI":"10.1016\/j.isci.2020.101250","article-title":"A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer","volume":"23","author":"Amedei","year":"2020","journal-title":"iScience"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1039\/D0OB01749C","article-title":"Synthesis of an STnThr Analogue, Structurally Based on a TnThr Antigen Mimetic","volume":"18","author":"Papi","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1039\/C9SC06334J","article-title":"Synthesis, Conformational Analysis and in Vivo Assays of an Anti-Cancer Vaccine That Features an Unnatural Antigen Based on an Sp2-Iminosugar Fragment","volume":"11","author":"Bermejo","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/bc900557v","article-title":"Stable GM3 Lactone Mimetic Raises Antibodies Specific for the Antigens Expressed on Melanoma Cells","volume":"21","author":"Arcangeli","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium Hydroxide Adjuvant Initiates Strong Antigen-Specific Th2 Responses in the Absence of IL-4- or IL-13-Mediated Signaling","volume":"163","author":"Brewer","year":"1999","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Stefanetti, G., Borriello, F., Richichi, B., Zanoni, I., and Lay, L. (2022). Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.808005"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/cb200358r","article-title":"Carbohydrate-Monophosphoryl Lipid A Conjugates Are Fully Synthetic Self-Adjuvanting Cancer Vaccines Eliciting Robust Immune Responses in the Mouse","volume":"7","author":"Wang","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1039\/C5SC01402F","article-title":"A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity","volume":"6","author":"Zhou","year":"2015","journal-title":"Chem. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1039\/C4OB00390J","article-title":"Synthesis and Evaluation of Monophosphoryl Lipid A Derivatives as Fully Synthetic Self-Adjuvanting Glycoconjugate Cancer Vaccine Carriers","volume":"12","author":"Zhou","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2018.10.013","article-title":"Carbohydrate-Based Adjuvants Activate Tumor-Specific Th1 and CD8+ T-Cell Responses and Reduce the Immunosuppressive Activity of MDSCs","volume":"440\u2013441","author":"Xu","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2297453","DOI":"10.1080\/21645515.2023.2297453","article-title":"Toll-like Receptor Agonists as Cancer Vaccine Adjuvants","volume":"20","author":"Jeon","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/2326-6066.CIR-18-0243","article-title":"TLR Stimulation during T-Cell Activation Lowers PD-1 Expression on CD8+ T Cells","volume":"6","author":"Zahm","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"101342","DOI":"10.1016\/j.tranon.2022.101342","article-title":"iNKT: A New Avenue for CAR-Based Cancer Immunotherapy","volume":"17","author":"Liu","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/acs.orglett.6b03591","article-title":"IgG Antibody Response Elicited by a Fully Synthetic Two-Component Carbohydrate-Based Cancer Vaccine Candidate with \u03b1-Galactosylceramide as Built-in Adjuvant","volume":"19","author":"Yin","year":"2017","journal-title":"Org. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1016\/j.apsb.2022.05.028","article-title":"Fully Synthetic Tn-Based Three-Component Cancer Vaccine Using Covalently Linked TLR4 Ligand MPLA and iNKT Cell Agonist KRN-7000 as Built-in Adjuvant Effectively Protects Mice from Tumor Development","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00262-007-0335-y","article-title":"A Polyvalent Vaccine for High-Risk Prostate Patients: \u201cAre More Antigens Better?\u201d","volume":"56","author":"Slovin","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/285664a0","article-title":"Carrier-Priming Leads to Hapten-Specific Suppression","volume":"285","author":"Herzenberg","year":"1980","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"14264","DOI":"10.1021\/jacs.6b05675","article-title":"Sialyl-Tn Polysaccharide A1 as an Entirely Carbohydrate Immunogen: Synthesis and Immunological Evaluation","volume":"138","author":"Shi","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.135.4.2319","article-title":"Carrier-Induced Epitopic Suppression, a Major Issue for Future Synthetic Vaccines","volume":"135","author":"Schutze","year":"1985","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/ja057244+","article-title":"Preparation and Evaluation of Unimolecular Pentavalent and Hexavalent Antigenic Constructs Targeting Prostate and Breast Cancer:\u2009 A Synthetic Route to Anticancer Vaccine Candidates","volume":"128","author":"Ragupathi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"O\u2019Cearbhaill, R.E., Ragupathi, G., Zhu, J., Wan, Q., Mironov, S., Yang, G., Spassova, M.K., Iasonos, A., Kravetz, S., and Ouerfelli, O. (2016). A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission. Cancers, 8.","DOI":"10.3390\/cancers8040046"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1002\/chem.200400074","article-title":"The Immunogenicity of the Tumor-Associated Antigen Lewisy May Be Suppressed by a Bifunctional Cross-Linker Required for Coupling to a Carrier Protein","volume":"10","author":"Buskas","year":"2004","journal-title":"Chem.\u2014A Eur. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e1579","DOI":"10.1002\/wnan.1579","article-title":"Virus-like Particles for Vaccination against Cancer","volume":"12","author":"Mohsen","year":"2020","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Chang, X., Krenger, P., Krueger, C.C., Zha, L., Han, J., Yermanos, A., Roongta, S., Mohsen, M.O., Oxenius, A., and Vogel, M. (2022). TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.827256"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Gomes, A.C., Roesti, E.S., El-Turabi, A., and Bachmann, M.F. (2019). Type of RNA Packed in VLPs Impacts IgG Class Switching\u2014Implications for an Influenza Vaccine Design. Vaccines, 7.","DOI":"10.3390\/vaccines7020047"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ebiom.2015.11.041","article-title":"Adjuvant-Enhanced CD4 T Cell Responses Are Critical to Durable Vaccine Immunity","volume":"3","author":"Martins","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.2741\/4073","article-title":"B Cell Toll-like Receptors and Immunoglobulin Class-Switch DNA Recombination","volume":"17","author":"Pone","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/cb400060x","article-title":"Boosting Immunity to Small Tumor-Associated Carbohydrates with Bacteriophage Q\u03b2 Capsids","volume":"8","author":"Yin","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/eji.201142361","article-title":"Nano-Particle Vaccination Combined with TLR-7 and -9 Ligands Triggers Memory and Effector CD8+ T-Cell Responses in Melanoma Patients","volume":"42","author":"Goldinger","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/acschembio.9b00381","article-title":"Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles","volume":"14","author":"Wu","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as Vaccine Delivery Systems: A Review of the Recent Advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_105","first-page":"406","article-title":"Shingrix: A New Herpes Zoster Vaccine","volume":"44","author":"Maltz","year":"2019","journal-title":"Pharm. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.vaccine.2021.12.046","article-title":"Efficacy and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Participants with a History of Cancer: Subgroup Analysis of a Global Phase 3 Randomized Clinical Trial","volume":"40","author":"Thomas","year":"2022","journal-title":"Vaccine"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1473-3099(23)00650-3","article-title":"Immunogenicity and Safety of a Booster Dose of a Self-Amplifying RNA COVID-19 Vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 Vaccine: A Double-Blind, Multicentre, Randomised, Controlled, Phase 3, Non-Inferiority Trial","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 Vaccine (MosquirixTM): An Overview","volume":"16","author":"Laurens","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1039\/C6CC02000C","article-title":"Multi-Component Self-Assembled Anti-Tumor Nano-Vaccines Based on MUC1 Glycopeptides","volume":"52","author":"Sun","year":"2016","journal-title":"Chem. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1021\/acsmacrolett.2c00291","article-title":"Liposome-Based Carbohydrate Vaccine for Simultaneously Eliciting Humoral and Cellular Antitumor Immunity","volume":"11","author":"Yao","year":"2022","journal-title":"ACS Macro Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0264-410X(99)00219-4","article-title":"Enhancement of the Immune Response to Poorly Immunogenic Gangliosides after Incorporation into Very Small Size Proteoliposomes (VSSP)","volume":"18","author":"Estevez","year":"1999","journal-title":"Vaccine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.vaccine.2005.01.114","article-title":"Very Small Size Proteoliposomes Derived from Neisseria Meningitidis: An Effective Adjuvant for Dendritic Cell Activation","volume":"24","author":"Mesa","year":"2006","journal-title":"Vaccine"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4161\/hv.24115","article-title":"NGcGM3\/VSSP Vaccine as Treatment for Melanoma Patients","volume":"9","author":"Osorio","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.seminoncol.2018.04.003","article-title":"GM3(Neu5Gc) Ganglioside: An Evolution Fixed Neoantigen for Cancer Immunotherapy","volume":"45","author":"Labrada","year":"2018","journal-title":"Semin. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-025-01127-8","article-title":"GMMA Decorated with Mucin 1 Tn\/STn Mimetics Elicit Specific Antibodies Response and Inhibit Tumor Growth","volume":"10","author":"Pesce","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e202300820","DOI":"10.1002\/ejoc.202300820","article-title":"Synthetic Outer Membrane Vesicles Bearing Tn Antigen","volume":"26","author":"Chieffo","year":"2023","journal-title":"Eur. J. Org. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/psc.2926","article-title":"Immune Activation with Peptide Assemblies Carrying Lewis y Tumor-Associated Carbohydrate Antigen","volume":"23","author":"Yamazaki","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/acsmacrolett.8b00052","article-title":"Biocompatible Single-Chain Polymer Nanoparticles Loaded with an Antigen Mimetic as Potential Anticancer Vaccine","volume":"7","author":"Gracia","year":"2018","journal-title":"ACS Macro Lett."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0167-7012(95)00041-0","article-title":"Use of Colloidal Gold to Obtain Antibiotin Antibodies","volume":"24","author":"Dykman","year":"1996","journal-title":"J. Microbiol. Methods"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/B:BIBU.0000014358.98422.9c","article-title":"Immunogenic Properties of Colloidal Gold","volume":"31","author":"Dykman","year":"2004","journal-title":"Biol. Bull."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C6SC03631G","article-title":"Immunological Properties of Gold Nanoparticles","volume":"8","author":"Dykman","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2019.02.025","article-title":"Gold Nanoparticles in Combinatorial Cancer Therapy Strategies","volume":"387","author":"Beik","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1021\/bc200606s","article-title":"Design and Synthesis of Multifunctional Gold Nanoparticles Bearing Tumor-Associated Glycopeptide Antigens as Potential Cancer Vaccines","volume":"23","author":"Sundgren","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bmc.2016.01.044","article-title":"Glycopeptide-Functionalized Gold Nanoparticles for Antibody Induction against the Tumor Associated Mucin-1 Glycoprotein","volume":"24","author":"Cai","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/acsbiomedchemau.1c00021","article-title":"Stable Gold-Nanoparticle-Based Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens","volume":"1","author":"Trabbic","year":"2021","journal-title":"ACS Bio Med Chem Au"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1515\/pac-2019-0210","article-title":"Nanoparticles for the Multivalent Presentation of a TnThr Mimetic and as Tool for Solid State NMR Coating Investigation","volume":"91","author":"Papi","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Barchi, J.J. (2022). Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.852147"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e1409","DOI":"10.1002\/wnan.1409","article-title":"Dendrimer-Based Nanocarriers: A Versatile Platform for Drug Delivery","volume":"9","author":"Hsu","year":"2017","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A New Class of Polymers: Starburst-Dendritic Macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polym. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/acs.bioconjchem.1c00587","article-title":"Dendrimer-Based Nanogels for Cancer Nanomedicine Applications","volume":"33","author":"Mekuria","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1055\/s-0036-1590796","article-title":"Synthesis of an MUC1 Glycopeptide Dendrimer Based on \u03b2-Cyclodextrin by Click Chemistry","volume":"28","author":"Chen","year":"2017","journal-title":"Synlett"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1399-3011.1997.tb01171.x","article-title":"Preparation of a Multiple Antigen Glycopeptide (MAG) Carrying the Tn Antigen. A Possible Approach to a Synthetic Carbohydrate Vaccine","volume":"49","author":"Bay","year":"1997","journal-title":"J. Pept. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1158\/0008-5472.CAN-04-0252","article-title":"A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates","volume":"64","author":"Perraut","year":"2004","journal-title":"Cancer Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1039\/C6OB01931E","article-title":"Large-Scale Synthesis and Structural Analysis of a Synthetic Glycopeptide Dendrimer as an Anti-Cancer Vaccine Candidate","volume":"15","author":"Ganneau","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00262-020-02503-0","article-title":"The Fully Synthetic Glycopeptide MAG-Tn3 Therapeutic Vaccine Induces Tumor-Specific Cytotoxic Antibodies in Breast Cancer Patients","volume":"69","author":"Rosenbaum","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1021\/acsabm.0c00863","article-title":"Poly(Amidoamine) Dendrimer-Gold Nanohybrids in Cancer Gene Therapy: A Concise Overview","volume":"3","author":"Li","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0040-4039(94)02481-P","article-title":"A Convenient Synthesis of Cyclic Peptides as Regioselectively Addressable Functionalized Templates (RAFT)","volume":"36","author":"Dumy","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/bc050010v","article-title":"Chemoselective Assembly and Immunological Evaluation of Multiepitopic Glycoconjugates Bearing Clustered Tn Antigen as Synthetic Anticancer Vaccines","volume":"16","author":"Grigalevicius","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/cbic.201700240","article-title":"Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate","volume":"18","author":"Richard","year":"2017","journal-title":"ChemBioChem"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"16283","DOI":"10.1002\/chem.201702708","article-title":"Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines","volume":"23","author":"Pifferi","year":"2017","journal-title":"Chem.\u2014A Eur. J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1039\/D0SC00544D","article-title":"Chemical Synthesis and Immunological Evaluation of New Generation Multivalent Anticancer Vaccines Based on a Tn Antigen Analogue","volume":"11","author":"Pifferi","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","article-title":"Polysaccharide Processing and Presentation by the MHCII Pathway","volume":"117","author":"Cobb","year":"2004","journal-title":"Cell"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.4049\/jimmunol.169.11.6149","article-title":"Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions","volume":"169","author":"Tzianabos","year":"2002","journal-title":"J. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1021\/jacs.3c03976","article-title":"Total Synthesis and Structural Studies of Zwitterionic Bacteroides Fragilis Polysaccharide A1 Fragments","volume":"145","author":"Wang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Lang, S., and Huang, X. (2020). Carbohydrate Conjugates in Vaccine Developments. Front. Chem., 8.","DOI":"10.3389\/fchem.2020.00284"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1039\/C4MD00038B","article-title":"Elucidating Structural Features of an Entirely Carbohydrate Cancer Vaccine Construct Employing Circular Dichroism and Fluorescent Labeling","volume":"5","author":"Trabbic","year":"2014","journal-title":"MedChemComm"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1039\/C4OB00128A","article-title":"Synthesis of the Tumor Associative \u03b1-Aminooxy Disaccharide of the TF Antigen and Its Conjugation to a Polysaccharide Immune Stimulant","volume":"12","author":"Bourgault","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"16207","DOI":"10.1021\/acs.joc.0c00320","article-title":"Synthesis of an Aminooxy Derivative of the GM3 Antigen and Its Application in Oxime Ligation","volume":"85","author":"Kleski","year":"2020","journal-title":"J. Org. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00262-018-2206-0","article-title":"Production of a Mouse Monoclonal IgM Antibody That Targets the Carbohydrate Thomsen-Nouveau Cancer Antigen Resulting in in Vivo and in Vitro Tumor Killing","volume":"67","author":"Trabbic","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Nishat, S., Hossain, M.K., Valentin, G., Hossain, F., Gamage, S., Wall, K.A., and Andreana, P.R. (2024). The Glycopeptide PV-PS A1 Immunogen Elicits Both CD4+ and CD8+ Responses. Vaccines, 12.","DOI":"10.3390\/vaccines12121375"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/abbs\/gmp062","article-title":"Effects of a Chemically Derived Homo Zwitterionic Polysaccharide on Immune Activation in Mice","volume":"41","author":"Meng","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_152","unstructured":"Telford, J., Berti, F., and Wack, A. (2009). Zwitterionization of Capsular Saccharides. (US20090136547A1)."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/4\/287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:26:15Z","timestamp":1774340775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/4\/287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":152,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["vaccines14040287"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14040287","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}